<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Definition and staging criteria of acute kidney injury in adults</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Definition and staging criteria of acute kidney injury in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Definition and staging criteria of acute kidney injury in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul M Palevsky, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Gary C Curhan, MD, ScD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Eric N Taylor, MD, MSc, FASN</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 31, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Acute kidney injury (AKI) refers to an abrupt decrease in kidney function, resulting in the retention of urea and other nitrogenous waste products and in the dysregulation of extracellular volume and electrolytes. The term AKI has largely replaced acute renal failure (ARF), reflecting the recognition that smaller decrements in kidney function that do not result in overt organ failure are of substantial clinical relevance and are associated with increased morbidity and mortality.</p><p>Several consensus definitions of AKI have been developed in order to provide a uniform definition of AKI. These definitions are based exclusively upon the serum creatinine and urine output and are used primarily to identify patients with AKI in epidemiologic and outcome studies. The overall utility of these definitions and staging systems in the clinical assessment and management of patients with AKI remains to be validated.</p><p>The potential etiologies, diagnosis, and management of AKI are discussed elsewhere:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7216.html" rel="external">"Etiology and diagnosis of prerenal disease and acute tubular necrosis in acute kidney injury in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7188.html" rel="external">"Diagnostic approach to adult patients with subacute kidney injury in an outpatient setting"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/14035.html" rel="external">"Overview of the management of acute kidney injury (AKI) in adults"</a>.)</p><p></p><p class="headingAnchor" id="H690890668"><span class="h1">DIAGNOSTIC CRITERIA</span><span class="headingEndMark"> — </span>The definition for AKI used in clinical and epidemiologic studies is based on specific criteria that have been sequentially developed. The Kidney Disease: Improving Global Outcomes (KDIGO) definition and staging system is the most recent and preferred definition [<a href="#rid1">1</a>]. Other criteria include the RIFLE criteria (Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease) [<a href="#rid2">2</a>] and a subsequent modification proposed by the Acute Kidney Injury Network (AKIN) and others [<a href="#rid3">3-5</a>]. These criteria are outlined in the table  (<a class="graphic graphic_table graphicRef83168" data-inline-graphics="83168" href="/d/graphic/83168.html" rel="external">table 1</a>).</p><p>The KDIGO guidelines define AKI as follows [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Increase in serum creatinine by ≥0.3 mg/dL (≥26.5 micromol/L) within 48 hours, or</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Increase in serum creatinine to ≥1.5 times baseline, which is known or presumed to have occurred within the prior seven days, or</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Urine volume &lt;0.5 mL/kg/hour for six hours</p><p></p><p>The KDIGO criteria allow for correction of volume status and obstructive causes of AKI prior to classification. Before diagnosing and classifying AKI, one should assess and optimize volume status and exclude obstruction. This is based upon AKIN criteria, on which the KDIGO definition is based. The AKIN state that these criteria should be used in the context of the clinical presentation and following adequate fluid resuscitation, when applicable, and that use of the urine output criteria alone requires exclusion of urinary tract obstruction or other easily reversible causes of reduced urine output. (See  <a class="medical medical_review" href="/d/html/102834.html" rel="external">"Evaluation of acute kidney injury among hospitalized adult patients"</a>.)</p><p>The timeframe for an absolute increase in serum creatinine of ≥0.3 mg/dL is retained from the AKIN definition (48 hours), while the timeframe for a ≥50 percent increase in serum creatinine reverted to the seven days originally included in the Acute Dialysis Quality Initiative (ADQI) RIFLE criteria.</p><p>The RIFLE and AKIN definitions are shown in the table  (<a class="graphic graphic_table graphicRef83168" href="/d/graphic/83168.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H486597861"><span class="h1">STAGING CRITERIA</span><span class="headingEndMark"> — </span>Using the Kidney Disease: Improving Global Outcomes (KDIGO) criteria, AKI is staged as follows:</p><p class="bulletIndent1"><span class="glyph">●</span>Stage 1 – Increase in serum creatinine to 1.5 to 1.9 times baseline, <strong>or</strong> increase in serum creatinine by ≥0.3 mg/dL (≥26.5 micromol/L), <strong>or</strong> reduction in urine output to &lt;0.5 mL/kg/hour for 6 to 12 hours.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Stage 2 – Increase in serum creatinine to 2.0 to 2.9 times baseline, <strong>or</strong> reduction in urine output to &lt;0.5 mL/kg/hour for ≥12 hours.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Stage 3 – Increase in serum creatinine to 3.0 times baseline, <strong>or</strong> increase in serum creatinine to ≥4.0 mg/dL (≥353.6 micromol/L), <strong>or</strong> reduction in urine output to &lt;0.3 mL/kg/hour for ≥24 hours, <strong>or</strong> anuria for ≥12 hours, <strong>or</strong> the initiation of kidney replacement therapy, <strong>or</strong>, in patients &lt;18 years, decrease in estimated glomerular filtration rate (eGFR) to &lt;35 mL/min/1.73 m<sup>2</sup>.</p><p></p><p>The KDIGO criteria differ from the RIFLE classification in that the KDIGO criteria only utilize changes in serum creatinine and urine output, not changes in GFR for staging, with the exception of children under the age of 18 years, for whom an acute decrease in eGFR to &lt;35 mL/min/1.73 m<sup>2</sup> is included in the criteria for stage 3 AKI.</p><p>As with the RIFLE and Acute Kidney Injury Network (AKIN) staging systems, KDIGO suggested that patients be classified according to criteria that result in the highest (ie, most severe) stage of injury.</p><p class="headingAnchor" id="H430237715"><span class="h1">LIMITATIONS</span><span class="headingEndMark"> — </span>There are a number of limitations to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria for AKI [<a href="#rid6">6-9</a>]. These limitations also apply to the older criteria (such as RIFLE and Acute Kidney Injury Network [AKIN]) that also rely solely on changes in creatinine or urine output.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Many etiologies cause AKI </strong>– A major flaw is that the criteria do not distinguish between the multiple etiologies that cause AKI. It is incorrect to treat AKI as a single disease, particularly grouping together hemodynamic causes (ie, "prerenal AKI") and acute tubular necrosis. To address this, the KDIGO guidelines specified that patients with AKI be evaluated promptly to determine cause [<a href="#rid1">1</a>]. Such evaluation is critical for patient care since reversible causes of AKI (such as obstruction) require specific interventions.</p><p></p><p class="bulletIndent1">In addition, different causes of AKI are associated with different long-term outcomes and prognoses, which is not always addressed in studies that utilize AKI criteria.</p><p></p><p class="bulletIndent1">Finally, from a research perspective, the development of therapeutic interventions requires the addition of etiologic or anatomic diagnoses to the criteria [<a href="#rid9">9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Use of urine output to define AKI </strong>– Another important issue is the use of urine output as a sole criterion for AKI. The KDIGO criteria define stages by change in either serum creatinine or urine output. (See <a class="local">'Diagnostic criteria'</a> above.)</p><p></p><p class="bulletIndent1">However, using urine output to define or stage AKI is not based on robust evidence. In one assessment of the RIFLE classification, which compared the serum creatinine and urine output criteria, the serum creatinine criteria were strong predictors of intensive care unit (ICU) mortality, whereas the urine output criteria did not independently predict mortality [<a href="#rid10">10</a>]. Brief durations of oliguria may just reflect insufficient volume resuscitation [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent1">Other studies, however, have suggested that urine output is predictive of mortality [<a href="#rid11">11,12</a>], and one study even suggested that urine output may be a more sensitive marker for AKI than serum creatinine [<a href="#rid13">13</a>].</p><p></p><p class="bulletIndent1">One study suggests that risks of death or kidney replacement therapy were highest when both the serum creatinine and urine output criteria were met [<a href="#rid14">14</a>]. However, although the criteria include both creatinine and urine output, in practice, the urine output is often omitted from studies [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1">Until this issue is resolved, it is reasonable to use the criteria that result in the least favorable strata assignment, as suggested in the Acute Dialysis Quality Initiative (ADQI) group [<a href="#rid2">2</a>] and affirmed by KDIGO [<a href="#rid1">1</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Determination of baseline creatinine </strong>– The determination of a baseline creatinine for individual patients is a third limitation. It is impossible to calculate the change in serum creatinine in patients who present with AKI but who do not have a baseline measurement of serum creatinine.</p><p></p><p class="bulletIndent1">The authors of the RIFLE criteria had initially suggested back-calculating an estimated baseline serum creatinine concentration using the four-variable Modification of Diet in Renal Disease (MDRD) equation, assuming a baseline glomerular filtration rate (GFR) of 75 mL/min/1.73 m<sup>2</sup> [<a href="#rid2">2</a>]. However, this approach has been demonstrated to result in significant misclassification [<a href="#rid6">6</a>] and should not be utilized.</p><p></p><p class="bulletIndent1">The European Renal Best Practice (ERBP) group recommended that the first documented serum creatinine be used as the baseline, rather than using historical values (ie, prior to the acute illness) or a calculated value based on a presumed baseline GFR of 75 mL/min [<a href="#rid6">6</a>]. However, the initial hospital creatinine value may already be elevated above the patient's usual baseline if the onset of AKI occurred prior to hospital admission. Creatinine production may also be reduced in the setting of acute illness, leading to an artifactual fall in admission serum creatinine [<a href="#rid15">15</a>]. Changes in volume of distribution of creatinine as the result of volume overload may also depress baseline creatinine values and blunt the rise in creatinine concentration during AKI. Some experts have suggested that an average of creatinine values measured 7 to 365 days prior to hospitalization best approximates the true baseline creatinine value [<a href="#rid16">16</a>].</p><p></p><p class="bulletIndent1">Even when a baseline creatinine is available, relying on small changes in serum creatinine for the diagnosis of AKI may be associated with a high rate of misdiagnosis, especially in patients with a baseline serum creatinine ≥1.5 mg/dL [<a href="#rid17">17</a>].</p><p></p><p>A more global concern raised by the Kidney Disease Outcomes Quality Initiative (KDOQI) work group is that the use of a definition based upon a biomarker, such as serum creatinine, or a variable, such as urine output, may result in a marked increase in the number of nephrology consultations, which would provide uncertain benefit to the patient [<a href="#rid7">7</a>]. As noted by an accompanying editorial to the KDOQI commentary, discretion is required to determine the clinical significance of a diagnosis of AKI [<a href="#rid18">18</a>].</p><p class="headingAnchor" id="H2445106908"><span class="h1">UTILITY IN EPIDEMIOLOGIC STUDIES</span><span class="headingEndMark"> — </span>The Kidney Disease: Improving Global Outcomes (KDIGO) criteria have greatest utility in epidemiologic studies and in defining consistent inclusion criteria and/or endpoints for clinical studies [<a href="#rid7">7,8</a>]. The severity of AKI stage is correlated with mortality risk and intensive care unit (ICU) and hospital length of stay [<a href="#rid10">10,19-31</a>].</p><p class="headingAnchor" id="H12441719"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/16930.html" rel="external">"Patient education: Acute kidney injury (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H8"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition of acute kidney injury (AKI)</strong> – AKI refers to the abrupt decrease in kidney function, resulting in the retention of urea and other nitrogenous waste products and in the dysregulation of extracellular volume and electrolytes. The term AKI has replaced acute renal failure (ARF), reflecting the recognition that smaller decrements in kidney function are associated with increased morbidity and mortality. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1">A consensus definition and criteria for AKI has been sequentially developed. The Kidney Disease: Improving Global Outcomes (KDIGO) AKI Workgroup definition and staging system is the preferred definition:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Increase in serum creatinine by ≥0.3 mg/dL (≥26.5 micromol/L) within 48 hours, or</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Increase in serum creatinine to ≥1.5 times baseline, which is known or presumed to have occurred within the prior seven days, or</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Urine volume &lt;0.5 mL/kg/hour for six hours</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Staging of AKI</strong> – Using the KDIGO criteria, AKI is staged as follows:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Stage 1 – Increase in serum creatinine to 1.5 to 1.9 times baseline, <strong>or</strong> increase in serum creatinine by ≥0.3 mg/dL (≥26.5 micromol/L), <strong>or</strong> reduction in urine output to &lt;0.5 mL/kg/hour for 6 to 12 hours.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Stage 2 – Increase in serum creatinine to 2.0 to 2.9 times baseline, <strong>or</strong> reduction in urine output to &lt;0.5 mL/kg/hour for ≥12 hours.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Stage 3 – Increase in serum creatinine to 3.0 times baseline, <strong>or</strong> increase in serum creatinine to ≥4.0 mg/dL (≥353.6 micromol/L), <strong>or</strong> reduction in urine output to &lt;0.3 mL/kg/hour for ≥24 hours, <strong>or</strong> anuria for ≥12 hours, <strong>or</strong> the initiation of kidney replacement therapy, <strong>or</strong>, in patients &lt;18 years, decrease in estimated glomerular filtration rate (eGFR) to &lt;35 mL/min/1.73 m<sup>2</sup>. (See <a class="local">'Staging criteria'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Limitations</strong> – The AKI definition does not distinguish between the multiple etiologies that can cause AKI. Other limitations include the use of urine output as a sole criterion for AKI, which has not been conclusively validated, and difficulty determining baseline kidney function among patients who have not had recent creatinine measurement. (See <a class="local">'Limitations'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2012; 2:8.</a></li><li><a class="nounderline abstract_t">Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8:R204.</a></li><li><a class="nounderline abstract_t">Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31.</a></li><li><a class="nounderline abstract_t">Levin A, Warnock DG, Mehta RL, et al. Improving outcomes from acute kidney injury: report of an initiative. Am J Kidney Dis 2007; 50:1.</a></li><li><a class="nounderline abstract_t">Molitoris BA, Levin A, Warnock DG, et al. Improving outcomes from acute kidney injury. J Am Soc Nephrol 2007; 18:1992.</a></li><li><a class="nounderline abstract_t">Ad-hoc working group of ERBP, Fliser D, Laville M, et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant 2012; 27:4263.</a></li><li><a class="nounderline abstract_t">Palevsky PM, Liu KD, Brophy PD, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis 2013; 61:649.</a></li><li><a class="nounderline abstract_t">James M, Bouchard J, Ho J, et al. Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis 2013; 61:673.</a></li><li><a class="nounderline abstract_t">Barasch J, Zager R, Bonventre JV. Acute kidney injury: a problem of definition. Lancet 2017; 389:779.</a></li><li><a class="nounderline abstract_t">Cruz DN, Bolgan I, Perazella MA, et al. North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): targeting the problem with the RIFLE Criteria. Clin J Am Soc Nephrol 2007; 2:418.</a></li><li><a class="nounderline abstract_t">Petäjä L, Vaara S, Liuhanen S, et al. Acute Kidney Injury After Cardiac Surgery by Complete KDIGO Criteria Predicts Increased Mortality. J Cardiothorac Vasc Anesth 2016.</a></li><li><a class="nounderline abstract_t">Qin JP, Yu XY, Qian CY, et al. Value of Kidney Disease Improving Global Outcomes Urine Output Criteria in Critically Ill Patients: A Secondary Analysis of a Multicenter Prospective Cohort Study. Chin Med J (Engl) 2016; 129:2050.</a></li><li><a class="nounderline abstract_t">Claure-Del Granado R, Macedo E, Chertow GM, et al. Toward the optimal dose metric in continuous renal replacement therapy. Int J Artif Organs 2012; 35:413.</a></li><li><a class="nounderline abstract_t">Kellum JA, Sileanu FE, Murugan R, et al. Classifying AKI by Urine Output versus Serum Creatinine Level. J Am Soc Nephrol 2015; 26:2231.</a></li><li><a class="nounderline abstract_t">Prowle JR, Kolic I, Purdell-Lewis J, et al. Serum creatinine changes associated with critical illness and detection of persistent renal dysfunction after AKI. Clin J Am Soc Nephrol 2014; 9:1015.</a></li><li><a class="nounderline abstract_t">Siew ED, Ikizler TA, Matheny ME, et al. Estimating baseline kidney function in hospitalized patients with impaired kidney function. Clin J Am Soc Nephrol 2012; 7:712.</a></li><li><a class="nounderline abstract_t">Lin J, Fernandez H, Shashaty MG, et al. False-Positive Rate of AKI Using Consensus Creatinine-Based Criteria. Clin J Am Soc Nephrol 2015; 10:1723.</a></li><li><a class="nounderline abstract_t">Levey AS, Levin A, Kellum JA. Definition and classification of kidney diseases. Am J Kidney Dis 2013; 61:686.</a></li><li><a class="nounderline abstract_t">Ali T, Khan I, Simpson W, et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol 2007; 18:1292.</a></li><li><a class="nounderline abstract_t">Uchino S, Bellomo R, Goldsmith D, et al. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 2006; 34:1913.</a></li><li><a class="nounderline abstract_t">Hoste EA, Clermont G, Kersten A, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006; 10:R73.</a></li><li><a class="nounderline abstract_t">Kuitunen A, Vento A, Suojaranta-Ylinen R, Pettilä V. Acute renal failure after cardiac surgery: evaluation of the RIFLE classification. Ann Thorac Surg 2006; 81:542.</a></li><li><a class="nounderline abstract_t">Ostermann M, Chang RW. Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med 2007; 35:1837.</a></li><li><a class="nounderline abstract_t">Ricci Z, Cruz D, Ronco C. The RIFLE criteria and mortality in acute kidney injury: A systematic review. Kidney Int 2008; 73:538.</a></li><li><a class="nounderline abstract_t">Bagshaw SM, George C, Dinu I, Bellomo R. A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008; 23:1203.</a></li><li><a class="nounderline abstract_t">Thakar CV, Christianson A, Freyberg R, et al. Incidence and outcomes of acute kidney injury in intensive care units: a Veterans Administration study. Crit Care Med 2009; 37:2552.</a></li><li><a class="nounderline abstract_t">Joannidis M, Metnitz B, Bauer P, et al. Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med 2009; 35:1692.</a></li><li><a class="nounderline abstract_t">Teles F, de Mendonça Uchôa JV, Mirelli Barreto Mendonça D, Falcão Pedrosa Costa A. Acute kidney injury in leptospirosis: the Kidney Disease Improving Global Outcomes (KDIGO) criteria and mortality . Clin Nephrol 2016; 86 (2016):303.</a></li><li><a class="nounderline abstract_t">Bıyık M, Ataseven H, Bıyık Z, et al. KDIGO (Kidney Disease: Improving Global Outcomes) criteria as a predictor of hospital mortality in cirrhotic patients. Turk J Gastroenterol 2016; 27:173.</a></li><li><a class="nounderline abstract_t">Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 2015; 41:1411.</a></li><li><a class="nounderline abstract_t">Coca SG, King JT Jr, Rosenthal RA, et al. The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans. Kidney Int 2010; 78:926.</a></li></ol></div><div id="topicVersionRevision">Topic 7238 Version 37.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : KDIGO Clinical Practice Guideline for Acute Kidney Injury</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15312219" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17331245" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17591518" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Improving outcomes from acute kidney injury: report of an initiative.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17596636" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Improving outcomes from acute kidney injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23045432" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23499048" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23518195" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28248160" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Acute kidney injury: a problem of definition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17699446" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): targeting the problem with the RIFLE Criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27856153" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Acute Kidney Injury After Cardiac Surgery by Complete KDIGO Criteria Predicts Increased Mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27569230" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Value of Kidney Disease Improving Global Outcomes Urine Output Criteria in Critically Ill Patients: A Secondary Analysis of a Multicenter Prospective Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22466995" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Toward the optimal dose metric in continuous renal replacement therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25568178" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Classifying AKI by Urine Output versus Serum Creatinine Level.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24742481" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Serum creatinine changes associated with critical illness and detection of persistent renal dysfunction after AKI.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22422536" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Estimating baseline kidney function in hospitalized patients with impaired kidney function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26336912" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : False-Positive Rate of AKI Using Consensus Creatinine-Based Criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23582249" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Definition and classification of kidney diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17314324" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Incidence and outcomes in acute kidney injury: a comprehensive population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16715038" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : An assessment of the RIFLE criteria for acute renal failure in hospitalized patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16696865" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16427848" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Acute renal failure after cardiac surgery: evaluation of the RIFLE classification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17581483" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Acute kidney injury in the intensive care unit according to RIFLE.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18160961" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : The RIFLE criteria and mortality in acute kidney injury: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17962378" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19602973" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Incidence and outcomes of acute kidney injury in intensive care units: a Veterans Administration study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19547955" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27805562" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Acute kidney injury in leptospirosis: the Kidney Disease Improving Global Outcomes (KDIGO) criteria and mortality .</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27015622" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : KDIGO (Kidney Disease: Improving Global Outcomes) criteria as a predictor of hospital mortality in cirrhotic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26162677" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20686452" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
